DTC
HELP

Deep Track Capital’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Deep Track Capital’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,313,137
Closed -$6.3M – 73
2026
Q1 		$6.3M Sell
1,313,137
-541,118
-29% -$3.5M 0.1% 61
2025
Q4 		$15.2M Buy
1,854,255
+854,255
+85% +$5.5M 0.27% 45
2025
Q3 		$5.89M Sell
1,000,000
-529,987
-35% -$3.76M 0.16% 45
2025
Q2 		$12.8M Hold
1,529,987
– – 0.41% 43
2025
Q1 		$9.7M Hold
1,529,987
– – 0.31% 50
2024
Q4 		$13.5M Hold
1,529,987
– – 0.5% 45
2024
Q3 		$13.6M Sell
1,529,987
-1
-0% -$10 0.43% 53
2024
Q2 		$15.8M Hold
1,529,988
– – 0.47% 48
2024
Q1 		$24M Buy
+1,529,988
New +$22.1M 0.69% 41

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Deep Track Capital's HELP Position: Q2 2026 in Review

Deep Track Capital sold out of Helus Pharma Inc. Common Stock (HELP) in Q2 2026, closing a stake of 1,313,137 shares — an estimated $6.3M sold.

Deep Track Capital first reported a position in HELP in Q1 2024 and held it in 9 quarters. The position peaked at $24M in Q1 2024. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Deep Track Capital reported no remaining Helus Pharma Inc. Common Stock position as of Q2 2026 after selling out during the quarter.
  • Deep Track Capital sold 1,313,137 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $6.3M.
  • Deep Track Capital first reported a position in Helus Pharma Inc. Common Stock in Q1 2024 and held it in 9 quarters.
  • Deep Track Capital's Helus Pharma Inc. Common Stock position peaked at $24M in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.